{"title":"Does the thickness of temporal muscle indicate sarcopenia and functional outcome in older patients with acute stroke?","authors":"Nedim Ongun","doi":"10.18071/isz.77.0417","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Aging, inactivity, malnutrition and diseases cause sarcopenia and stroke is an important reason of sarcopenia. The aim of this study was to determine the sarcopenia and to evaluate the relationship between functional outcome and temporal muscle thickness using brain CT in older acute stroke patients. </p><p><strong>Methods: </strong>A retrospective study was conducted with acute stroke patients in a single neurology clinic. A total of 114 patients aged 65 years and older were included. Temporal muscle thickness was measured manually using brain computed tomography on admission and third month. Sarcopenia risk and modified Rankin scale scores at 3 months after stroke were assessed. </p><p><strong>Results: </strong>The mean temporal muscle thickness was 5.85±0.96 on admission and 5.67±0.97 on third month in the entire group (p=0.004). Patients with sarcopenia risk score ≥4 on third month, the mean temporal muscle thickness was 5.63±1.02 and 5.32±0.98 on admission and 3rd month respectively (p<0.001). There was a significant correlation between baseline temporal muscle thickness and age (r=-0.728, p<0.001) and body mass index (r= 0.360 , p=0.017). 23 patients (20.1%) had poor functional outcome at 3 months after stroke (mRS>3). A significant correlation was found between temporal muscle thickness on admission and the third month modified Rankin scale score (r=-0.613, p<0.001). </p><p><strong>Conclusion: </strong>Measurement of temporal muscle thickness using brain CT in stroke patients may be a useful method for muscle mass determination and treatment of sarcopenia. </p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 11-12","pages":"417-421"},"PeriodicalIF":0.9000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ideggyogyaszati Szemle-Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18071/isz.77.0417","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: Aging, inactivity, malnutrition and diseases cause sarcopenia and stroke is an important reason of sarcopenia. The aim of this study was to determine the sarcopenia and to evaluate the relationship between functional outcome and temporal muscle thickness using brain CT in older acute stroke patients.
Methods: A retrospective study was conducted with acute stroke patients in a single neurology clinic. A total of 114 patients aged 65 years and older were included. Temporal muscle thickness was measured manually using brain computed tomography on admission and third month. Sarcopenia risk and modified Rankin scale scores at 3 months after stroke were assessed.
Results: The mean temporal muscle thickness was 5.85±0.96 on admission and 5.67±0.97 on third month in the entire group (p=0.004). Patients with sarcopenia risk score ≥4 on third month, the mean temporal muscle thickness was 5.63±1.02 and 5.32±0.98 on admission and 3rd month respectively (p<0.001). There was a significant correlation between baseline temporal muscle thickness and age (r=-0.728, p<0.001) and body mass index (r= 0.360 , p=0.017). 23 patients (20.1%) had poor functional outcome at 3 months after stroke (mRS>3). A significant correlation was found between temporal muscle thickness on admission and the third month modified Rankin scale score (r=-0.613, p<0.001).
Conclusion: Measurement of temporal muscle thickness using brain CT in stroke patients may be a useful method for muscle mass determination and treatment of sarcopenia.
期刊介绍:
The aim of Clinical Neuroscience (Ideggyógyászati Szemle) is to provide a forum for the exchange of clinical and scientific information for a multidisciplinary community. The Clinical Neuroscience will be of primary interest to neurologists, neurosurgeons, psychiatrist and clinical specialized psycholigists, neuroradiologists and clinical neurophysiologists, but original works in basic or computer science, epidemiology, pharmacology, etc., relating to the clinical practice with involvement of the central nervous system are also welcome.